Beijing Gingko Group (BGG), a world leader in the production of authentic Bilberry Extract 25% announces expanded manufacturing and supply of this popular dietary supplement. “At a time when adulterated bilberry products are increasingly being identified and banned, BGG is filling the void with its HPLC-tested Ginnovay™ Bilberry Extract 25%”, states BGG N.A.’s President, Jay Lee, Ph.D., M.D..
BGG will begin bilberry extract 25% production at its new, GMP certified, state of the art production facility in Changping, China later this month. The new production facility is located on the same campus as the R&D and QC building and will significantly expand production capacity. Already an industry benchmark for product quality and consistency, BGG’s new production facility will ensure the long term viability of this important nutraceutical.
Bilberry extract continues to be an excellent ingredient for eye health formulations due to its proven safety and efficacy as demonstrated in numerous clinical studies. However, only bilberry extract manufactured from premium bilberries, collected from the forests of Northern Europe, are capable of delivering these clinically proven health benefits. Request fruit traceability documentation and full HPLC testing to ensure you’re using bilberry extract that will deliver real benefits to your customers.
Ginnovay™ is widely perceived as the bilberry extract of choice in global markets, such as Japan, North America and Europe due to its consistent HPLC profile, product availability and superior value. “We see customers increasingly looking for high quality bilberry extract that can be positively identified as Vaccinium myrtillus, deliver a minimum of 25% anthocyanidins by HPLC and be domestically warehoused for short lead times and quick delivery”, says Dr. Lee.
BGG invites customers to take advantage of BGG’s superior quality, scientific support, domestic inventory, and ultimately, superior value.